Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased p53 activity does not accelerate telomere-driven ageing.

Isabel García-Cao1, Marta García-Cao, Antonia Tomás-Loba

  • 1Tumor Suppression Group, Spanish National Cancer Center, Madrid.

EMBO Reports
|April 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Nature cancer·2026
Same author

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

European journal of haematology·2026
Same author

Evaluation of IVIG for Prevention of Infections Occurring On-study and Treatment of Infection of Solid Organ Recipients With Secondary Antibody Deficiency: A Phase 2 Randomized Clinical Trial.

Transplantation direct·2026
Same author

A targeted metabolomic method to detect epigenetically relevant metabolites.

Molecular metabolism·2026
Same author

Senotoxins target senescence via lipid binding specificity, ion imbalance and lipidome remodeling.

Nature aging·2026
Same author

Circadian system and aging: where both times interact.

Frontiers in aging·2025

The tumor suppressor p53 actively eliminates cells with telomere damage, a key aging factor. Increased p53 function did not alter the pace of telomere-driven aging in mice.

Area of Science:

  • Cellular senescence and aging research
  • Genetics and molecular biology
  • DNA damage response pathways

Background:

  • Aging is multifaceted, with telomere loss being a significant contributor to age-associated damage.
  • The tumor suppressor protein p53 plays a critical role in cellular responses to stress and damage.
  • Understanding p53's role in telomere-driven aging is crucial for discriminating aging causes.

Purpose of the Study:

  • To investigate if p53 contributes to the elimination of cells with damaged telomeres.
  • To determine the impact of enhanced p53 activity on telomere-driven aging.
  • To elucidate the specific role of p53 in managing telomere-induced cellular damage.

Main Methods:

  • Generated genetically modified mice with three functional copies of the p53 gene (super-p53) on a telomerase-deficient background.

Related Experiment Videos

  • Assessed chromosomal abnormalities and DNA damage levels in various tissues of the experimental mice.
  • Compared telomere-derived damage load in super-p53/telomerase-null mice versus normal-p53/telomerase-null mice.

    • Main Results:

    • A significant reduction in the in vivo load of telomere-derived chromosomal damage was observed in super-p53/telomerase-null mice.
    • Enhanced p53 activity did not accelerate or decelerate the progression of telomere-driven aging.
    • p53 demonstrated an active role in clearing cells exhibiting telomere damage.

    Conclusions:

    • p53 plays an active role in the elimination of cells with telomere damage.
    • Increased p53 activity does not promote or hasten telomere-driven aging.
    • These findings help differentiate the mechanisms underlying various aging processes.